PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 9.80K shares, a 83.53% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 17.80K shares, a 49.14% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 80.30K shares, a 73.53% decline from fiscal 2025.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 303.40K shares, a 31.09% decline from fiscal 2024.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 440.30K shares, a 114.57% increase from fiscal 2023.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 205.20K shares, a 9.20% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | 27.60K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 9.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 80.30K shares 10-K · filed 2026-05-14 |
| 2025-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | 130.00K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | 17.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 300.60K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 52.70K shares 10-Q · filed 2026-08-06 | 317.80K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 59.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 303.40K shares 10-K · filed 2026-05-14 |
| 2024-12-31 | 170.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | 415.30K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-09-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 283.20K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-06-30 | 38.30K shares 10-Q · filed 2025-08-07 | 305.70K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-03-31 | 171.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 440.30K shares 10-K · filed 2026-05-14 |
| 2023-12-31 | 38.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | 273.90K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-09-30 | 57.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | 396.50K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-06-30 | 172.90K shares 10-Q · filed 2024-08-08 | 339.00K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-03-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09 | 205.20K shares 10-K · filed 2025-05-09 |
| 2022-12-31 | 161.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | 234.90K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-02 | 177.50K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-06-30 | 39.10K shares 10-Q · filed 2023-08-03 | 197.20K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-03-31 | 34.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15 | 226.00K shares 10-K · filed 2024-05-15 |
| 2021-12-31 | 103.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-02 | 245.10K shares derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-09-30 | 19.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | 144.40K shares derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-06-30 | 67.90K shares 10-Q · filed 2022-08-04 | 127.00K shares derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-03-31 | 53.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05 | 119.60K shares 10-K · filed 2023-05-05 |
| 2020-12-31 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | 77.70K shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-09-30 | 2.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | 92.30K shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-06-30 | 60.50K shares 10-Q · filed 2021-08-05 | 99.10K shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-03-31 | 11.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-06 | 47.90K shares 10-K · filed 2022-05-06 |
| 2019-12-31 | 17.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04 | 36.00K shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-09-30 | 9.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | 78.90K shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-06-30 | 9.30K shares 10-Q · filed 2020-08-06 | 74.20K shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-07 | 97.70K shares 10-K · filed 2021-05-07 |
| 2018-12-31 | 60.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-06 | 102.40K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-09-30 | 4.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-10-31 | 41.90K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-06-30 | 32.80K shares 10-Q · filed 2019-08-01 | 74.70K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-03-31 | 4.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | 55.70K shares 10-K · filed 2020-05-08 |
| 2017-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | 69.90K shares derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-09-30 | 37.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-01 | 70.70K shares derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-06-30 | 13.80K shares 10-Q · filed 2018-08-02 | 34.90K shares derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-03-31 | 18.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-13 | 126.80K shares 10-K · filed 2019-05-13 |
| 2016-12-31 | 800.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | 119.00K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-09-30 | 1.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | 118.20K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-06-30 | 105.70K shares 10-Q · filed 2017-08-03 | 123.30K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-03-31 | 11.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10 | 348.00K shares 10-K · filed 2018-05-10 |
| 2015-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-02 | 359.80K shares derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-09-30 | 6.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | 438.80K shares derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-06-30 | 330.40K shares 10-Q · filed 2016-08-04 | 622.90K shares derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-03-31 | 22.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-17 | 386.30K shares 10-K · filed 2017-05-17 |
| 2014-12-31 | 79.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | 378.50K shares derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-09-30 | 190.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05 | 350.00K shares derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-06-30 | 93.80K shares 10-Q · filed 2015-08-06 | 673.80K shares derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-03-31 | 15.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-17 | 605.00K shares 10-K · filed 2016-05-17 |
| 2013-12-31 | 50.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | 667.90K shares derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-09-30 | 514.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | 1.32M shares derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-06-30 | 25.00K shares 10-Q · filed 2014-08-07 | 804.70K shares derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-03-31 | 78.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14 | 786.50K shares 10-K · filed 2015-05-14 |
| 2012-12-31 | 701.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07 | 741.20K shares derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-07 | 39.50K shares derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-06-30 | 6.80K shares 10-Q · filed 2013-08-01 | 40.40K shares derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-03-31 | 32.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | 86.90K shares 10-K · filed 2014-05-19 |
| 2011-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07 | |
| 2011-09-30 | 900.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | |
| 2011-06-30 | 53.30K shares 10-Q · filed 2012-08-09 | |
| 2011-03-31 | 86.90K shares 10-K · filed 2013-05-17 | |
| 2010-03-31 | 33.80K shares 10-K · filed 2013-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |